POINT/COUNTERPOINT: Is There a Role for HCT as Upfront Therapy for Myelofibrosis in the Era of JAK Inhibitors? Case Vignette

Track: BMT Tandem "Scientific" Meeting
Saturday, March 1, 2014, 10:30 AM-12:00 PM
Texas C (Gaylord Texan)
Vikas Gupta, MD , Department of Medicine, Princess Margaret Cancer Center, Toronto, ON, Canada
Audio File Recorded Presentation
Disclosures:
V. Gupta, Novartis, Advisory board: Advisory Board, Consultancy, Honoraria and Research Funding
Incyte, Advisory Board: Advisory Board and Honoraria
See more of: Myeloproliferative Neoplasms: Biological and Therapeutic Advances
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation | Next Presentation >>